Our mission: Exponentially increase the speed and quality of life-saving research
Hey, we get it. You have options. Recruiters ping you on LinkedIn. Job ads follow you online. And you’ve heard all the pitches. Great office. Great perks. Great culture. You expect it. But if you’re here, you want more. To do more. To be more. So here’s our pitch.
At BenchSci, you speed up science. Our customers are scientists in academic labs and pharmaceutical companies. They research new treatments to horrible diseases, like cancer, Zika, and Alzheimer’s. To do this, they design experiments and select supplies. It takes time and is error-prone. Our technology helps. We use machine learning to assist their experiment design and supply selection. With our technology, they run more successful experiments faster. This increases the speed of drug discovery.
At BenchSci, you work with authorities in emerging technologies. Our team comprises experts in science, technology, engineering, and commercialization. We come together to realize our mission. And to learn, have fun, and grow while doing it.
At BenchSci, you can work with the world’s leading AI advisors and investors. Our advisory board includes Richard Zemel, Research Director of the Vector Institute. Our investors include Gradient Ventures, Google’s AI fund. As extensions of our team, they keep us ahead of trends in technology and business.
At BenchSci, you get the right balance between being quick and being smart. Our core values are FASTT — Focused Advancement with Speed, Tenacity, and Transparency. Here’s what we mean: